Home › Funds › PERCEPTIVE ADVISORS LLC › RLAY

PERCEPTIVE ADVISORS LLC position in RLAY

RELAY THERAPEUTICS INC · Health Care

PERCEPTIVE ADVISORS LLC reported holding 14,106,187 shares of RLAY (RELAY THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$263.9M, representing 4.19% of its reported portfolio and ranking #6 among its reported holdings. PERCEPTIVE ADVISORS LLC has disclosed RLAY holdings in 4 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)14.11M sh
Reported value held$263.93M
Portfolio Weight4.19%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PERCEPTIVE ADVISORS LLC's RLAY position evolved

PERCEPTIVE ADVISORS LLC first disclosed a stake in RLAY in Q3 2023 at 1,943,097 shares (US$16.3M). The position peaked in Q2 2026 at 14,106,187 shares, worth US$263.9M. Across 4 filings, PERCEPTIVE ADVISORS LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 14,106,187 shares valued at US$263.9M — an increase of 4,355,046 shares quarter over quarter.. Notable position changes include a 412% increase in Q1 2026 (shares rose 88% over the following quarter), a 45% increase in Q2 2026 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.94M $16.34M New
Q4 2025 1.90M $16.10M New
Q1 2026 9.75M $97.02M Add
Q2 2026 14.11M $263.93M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RLAY and 13F data

RLAY (RELAY THERAPEUTICS INC) is a Health Care company. 64 other funds we track also report a position in RLAY — the largest reported positions include SB INVESTMENT ADVISERS (UK) LTD (US$522.1M), Casdin Capital (US$300.0M), Commodore Capital LP (US$224.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RLAY

All RLAY fund holders →

FAQ

How long has PERCEPTIVE ADVISORS LLC held RLAY?

PERCEPTIVE ADVISORS LLC has disclosed RLAY holdings in 4 of the last 12 reported quarters, going back to Q3 2023.

What is PERCEPTIVE ADVISORS LLC's current position in RLAY?

As of Q2 2026, PERCEPTIVE ADVISORS LLC holds 14.11M shares of RLAY (RELAY THERAPEUTICS INC), valued at $263.93M, representing 4.19% of its reported portfolio and ranking #6.

Has PERCEPTIVE ADVISORS LLC been buying or selling RLAY?

In the latest 13F filing (Q2 2026), PERCEPTIVE ADVISORS LLC increased its position in RLAY. The position peaked in Q2 2026 at 14.11M shares.

Which other funds hold RLAY?

Other major institutional holders of RLAY include SB INVESTMENT ADVISERS (UK) LTD, Casdin Capital, Commodore Capital LP, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.